{"publish_date":{"7230627":20141109,"7226087":20141109,"7222948":20141109,"7224071":20141109},"url":{"7230627":"http:\/\/www.healthline.com\/health-news\/success-in-first-human-trial-hepatitis-c-vaccine-110914","7226087":"http:\/\/www.ajmc.com\/conferences\/AASLD2014\/The-Real-World-Experience-With-Simprevir-and-Sofosbuvir-Based-Regimens-in-Hep-C-Treatment","7222948":"http:\/\/in.reuters.com\/article\/2014\/11\/10\/us-merck-co-hepatitis-idINKCN0IU00K20141110","7224071":"http:\/\/news.yahoo.com\/merck-four-week-hep-c-regimen-gileads-sovaldi-001648224--finance.html"},"topic":{"7230627":"hepat","7226087":"hepat","7222948":"hepat","7224071":"hepat"},"model1_prediction":{"7230627":1,"7226087":1,"7222948":1,"7224071":1},"model1_prediction_prob":{"7230627":0.8954391869,"7226087":0.6325846763,"7222948":0.5347131824,"7224071":0.5210368338},"title":{"7230627":"Scientists See Success in First Human Trial of Hepatitis C Vaccine","7226087":"The Real-World Experience With Simeprevir- and Sofosbuvir-Based Regimens in Hep C Treatment","7222948":"Merck four-week hep C regimen with Gilead's Sovaldi comes up short","7224071":"Merck 4-week hep C regimen with Gilead's Sovaldi comes up short"}}